InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod ...Middle East

STOCKHOLM, Aug. 2, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new formulation patent for the drug candidate cobitolimod has been granted by the European Patent Office. The patent provides protection of the enema formulation of cobitolimod, that is...

Hence then, the article about index pharmaceuticals has been granted a new patent in europe for the commercial formulation of cobitolimod was published today ( Wednesday 02/08/2023 - 09:44 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod )

Also on site :

• Trump Wants To”Unleash Hell” In 2026; POTUS Tries To Go Full Maximus With A Misguided ‘Gladiator’ Flex
• GCE Global Solutions Corp. Announces Strategic Acquisition of GCE Payroll Advisers Inc. to Strengthen Global EOR and Payroll Platform
• Mickey Rourke Sued for $59,100 in Unpaid Rent, Facing Eviction